Nugenesys Pharmaceuticals Private Limited
About Nugenesys Pharmaceuticals Private Limited
Data last updated:
Nugenesys Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the manufacturing segment of the paper and packaging sector. It was incorporated on 12 December 2024.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21002MH2024PTC436328.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Taibachem Healthcare Private Limited. It is led by directors Shoyeb Abdul Gafoor Mandlekar and Saba Shoyeb Mandlekar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.85 Lakh. For the same year it recorded a net loss of ₹87,430 (net margin -8.9%) and EBITDA of -₹87,135 (EBITDA margin -8.8%).
Court records list 4 cases involving the company, including 1 filed by the company and 3 filed against it; 2 cases are pending.
Company details
Contact details
Nugenesys Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra.
- Registered AddressFlat No 801 Dosti Planet, Emerald B – Wing, Thane, Maharashtra, India – 400612
- IndustryPaper, Manufacturing, Paper & Paper Products
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nugenesys Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Nugenesys Pharmaceuticals Private Limited, buy the company report.
Financials of Nugenesys Pharmaceuticals Private Limited
FY 2025 filings availableNugenesys Pharmaceuticals Private Limited reported revenue of ₹9.85 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹87,135 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹87,430 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -8.8% |
| Net Profit Margin | -8.9% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nugenesys Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nugenesys Pharmaceuticals Private Limited
Nugenesys Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shoyeb Abdul Gafoor Mandlekar Also directs: Zyvieon Healthcare Private Limited | Director | 12 Dec 2024 | 1 Years 10 Months | Current |
| Saba Shoyeb Mandlekar | Additional Director | 03 Jun 2025 | 1 Years 5 Months | Current |
Legal cases
Nugenesys Pharmaceuticals Private Limited has 4 court cases on record: 1 filed by Nugenesys Pharmaceuticals, 3 filed against it. 2 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 1 | 0 |
| Supreme Court | 2 | 2 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (Special Leave Petition (Civil)) | Filed against the company by Celagenex Research (India) Pvt. Ltd. | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Celagenex Research (India) Pvt. Ltd. | Disposed |
| High Court of Delhi | Court case (FAO(OS) (COMM)) | Filed by the company against Celagenex Research (India) Pvt. Ltd. & Anr. | Disposed |
| Supreme Court | Court case | Filed against the company by an individual | Pending |
To see the full case history of Nugenesys Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nugenesys Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nugenesys Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nugenesys Pharmaceuticals Private Limited has 3 board changes on record since 2024: 3 appointments. The latest: Saba Shoyeb Mandlekar was appointed as Additional Director on 03 Jun 2025.
Frequently asked questions
Nugenesys Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in manufacturing, within the paper industry. It was incorporated on 12 December 2024 (2+ years old) and is registered under CIN U21002MH2024PTC436328.
Nugenesys Pharmaceuticals has 2 current directors:
- Shoyeb Abdul Gafoor Mandlekar - Director
- Saba Shoyeb Mandlekar - Additional Director
The latest financial statements of Nugenesys Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Nugenesys Pharmaceuticals is U21002MH2024PTC436328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nugenesys Pharmaceuticals has 4 court cases on record: 1 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.
Nugenesys Pharmaceuticals was incorporated on 12 December 2024, making it 2+ years old. It is registered with the Registrar of Companies, Mumbai.
Saba Shoyeb Mandlekar was appointed as Additional Director on 03 Jun 2025. Aafreen Fayas Sayed was appointed as Director on 12 Dec 2024. Shoyeb Abdul Gafoor Mandlekar was appointed as Director on 12 Dec 2024.
The registered office of Nugenesys Pharmaceuticals is at Flat No 801 Dosti Planet, Emerald B – Wing, Thane, Maharashtra, India – 400612.
Nugenesys Pharmaceuticals operates in the paper industry, in the manufacturing segment.
Yes. Nugenesys Pharmaceuticals was formerly known as Taibachem Healthcare Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
